PROCEEDINGS VOLUME 4952
BIOMEDICAL OPTICS | 25-31 JANUARY 2003
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XII
IN THIS VOLUME

0 Sessions, 26 Papers, 0 Presentations
BIOMEDICAL OPTICS
25-31 January 2003
San Jose, CA, United States
Mechanisms of Photodamage
Proc. SPIE 4952, From molecular PDT damage to cellular PDT responses: attempts at bridging the gap on the role of Bcl-2, 0000 (13 June 2003); doi: 10.1117/12.488633
Proc. SPIE 4952, Promotion of PDT efficacy by bile acids, 0000 (13 June 2003); doi: 10.1117/12.473615
Proc. SPIE 4952, Development of an in-vivo model for the study of photodynamic therapy and anti-angiogenic treatments, 0000 (13 June 2003); doi: 10.1117/12.474104
Preclinical Studies and Dosimetry
Proc. SPIE 4952, Metronomic photodynamic therapy (<i>m</i>PDT): concepts and technical feasibility in brain tumor, 0000 (13 June 2003); doi: 10.1117/12.479435
Proc. SPIE 4952, Increasing oxygenation and radiation sensitivity following photodynamic therapy with verteporfin in the RIF-1 tumor, 0000 (13 June 2003); doi: 10.1117/12.473594
Proc. SPIE 4952, Numerical light dosimetry in murine tissue: analysis of tumor curvature and angle of incidence effects upon fluence in the tissue, 0000 (13 June 2003); doi: 10.1117/12.474081
Proc. SPIE 4952, Effect of photodynamic therapy with verteporfin on tumor blood flow, 0000 (13 June 2003); doi: 10.1117/12.474082
Proc. SPIE 4952, Light dosimetry at tissue surfaces for small circular fields, 0000 (13 June 2003); doi: 10.1117/12.474144
Proc. SPIE 4952, In-vivo measurements of penetration depth, oxygenation, and drug concentration using broadband absorption spectroscopy in human tissues before and after photodynamic therapy, 0000 (13 June 2003); doi: 10.1117/12.474142
Preclinical and Clinical Studies
Proc. SPIE 4952, Effects of telomerase expression on photodynamic therapy of Barrett's esophagus, 0000 (13 June 2003); doi: 10.1117/12.479434
Proc. SPIE 4952, Fluorescence-guided resection of intracranial VX2 tumor in a preclinical model using 5-aminolevulinic acid (ALA): preliminary results, 0000 (13 June 2003); doi: 10.1117/12.479426
Proc. SPIE 4952, Clinical studies of photodynamic therapy for malignant brain tumors: facial nerve palsy after temporal fossa photoillumination, 0000 (13 June 2003); doi: 10.1117/12.479428
Proc. SPIE 4952, Studies of a novel photosensitizer palladium-bacteriopheophorbide (Tookad) for the treatment of prostate cancer, 0000 (13 June 2003); doi: 10.1117/12.474097
Proc. SPIE 4952, Effects of TOOKAD-PDT on canine prostates pre-treated with ionizing radiation, 0000 (13 June 2003); doi: 10.1117/12.474099
Proc. SPIE 4952, Repetition-rate-dependent oxygen consumption modifies cytotoxicity in photodynamic therapy using pulsed light, 0000 (13 June 2003); doi: 10.1117/12.474150
Proc. SPIE 4952, Noninvasive monitoring hemodynamic responses in RIF tumors during and after PDT, 0000 (13 June 2003); doi: 10.1117/12.474101
Proc. SPIE 4952, Ultrasensitive diode-laser-based monitor for singlet oxygen, 0000 (13 June 2003); doi: 10.1117/12.479433
Proc. SPIE 4952, Photodynamic therapy of breast cancer with photosense, 0000 (13 June 2003); doi: 10.1117/12.479431
Poster Session
Proc. SPIE 4952, Time-delayed fluorescence imaging of a porphycene derivative, 0000 (13 June 2003); doi: 10.1117/12.473596
Proc. SPIE 4952, Gastroenteric cancers detection by Raman spectroscopy of human serum, 0000 (13 June 2003); doi: 10.1117/12.473598
Proc. SPIE 4952, Light dosimetry for photodynamic therapy in the esophagus, 0000 (13 June 2003); doi: 10.1117/12.474083
Proc. SPIE 4952, Histological study of hamster buccal mucosa following topical application of DMBA and exposition to low-power 337-nm laser light, 0000 (13 June 2003); doi: 10.1117/12.474125
Proc. SPIE 4952, Hyperoxygenation enhances the direct tumor cell killing of photofrin-mediated photodynamic therapy, 0000 (13 June 2003); doi: 10.1117/12.474147
Proc. SPIE 4952, Anticancer effect and cell cycle regulation of photodynamic therapy (PDT) using 9- hydroxypheophorbide-a and 660-nm diode laser, 0000 (13 June 2003); doi: 10.1117/12.474152
Proc. SPIE 4952, High-throughput screening system for the study of phototoxicity of photosensitizers in vitro, 0000 (13 June 2003); doi: 10.1117/12.480277
Preclinical Studies and Dosimetry
Proc. SPIE 4952, Bioluminescence monitoring of photodynamic therapy response of rat gliosarcoma in vitro and in vivo, 0000 (13 June 2003); doi: 10.1117/12.488634
Back to Top